Jafron Biomedical Co.,Ltd.

    Jurisdiction
    China
    ISIN
    CNE100002995 (300529.SZ)
    Sectors
    1. Healthcare
    2. Medical - Devices

    Scores

    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    8 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    5 / 7

    Profile

    Jafron Biomedical Co.,Ltd. engages in the research, development, production, and marketing of biological materials and medical devices in China. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €280.31M
    Gross margin
    80.5%
    EBIT
    €102.82M
    EBIT margin
    36.7%
    Net income
    €79.56M
    Net margin
    28.4%

    Statement period: - (published )

    Dividends

    Last dividend amount
    CN¥0.80
    Ex date
    Payment date
    Dividend payout ratio
    98.7%

    Add to watchlist

    Notifications